Abstract:Mammalian tissues have phosphatidylcholine (PC)-specific phospholipase C (PC-PLC) to hydrolyze PC for regulating steady-state levels of PC and diacylglycerol (DAG). Abnormally high levels of PC-PLC activity in various tissues have been linked to many disease progressions. Inhibition of PC-PLC activity has an impact on the antiinflammatory effect, protection of endothelium cell functions, and metabolic diseases such as atherosclerosis. However, until very recently, we still do not know the gene(s) responsible for mammalian PC-PLCs. Most of our knowledge about the PC-PLC was obtained from using a PC-PLC inhibitor, tricyclodecan-9-yl-potassium xanthate (D609). Interestingly, D609 also is an inhibitor of sphingomyelin synthase (SMS), which has two isoforms, SMS1 and SMS2. Thus, we hypothesized that both SMS1 and SMS2 has dual activities, i.e., SM synthase and PC-PLC. In the current review, we summarized the function of PC-PLC, linking it to SMS1 and SMS2. We hope to give our readers a new vision about mammalian PC-PLCs.

Mammalian phosphatidylcholine-specific phospholipase Cs